Business
Hofseth BioCare ASA: NOTICE OF EXTRAORDINARY GENERAL MEETING
Reference is made to the stock exchange announcement by Hofseth BioCare ASA ("HBC" or the "Company") on 27 October 2025 regarding (i) the completion of a private placement (the "Private Placement") of new shares in the Company the "Offer Shares"), the completion of which by delivery of Offer Shares in tranche 2 (the "T2 Offer Shares") is subject to, among other things, an extraordinary general meeting (the "EGM") resolving to issue the T2 Offer Shares in the Private Placement and (ii) a potentia
About this update from Hofseth Biocare Asa
[{"type":"image","alt":"Hofseth Biocare ASA","displaySize":"","headline":null,"caption":"Hofseth Biocare ASA","className":"","disableSlideshowImg":false,"size":{"original":{"width":300,"height":89,"url":"https://media.zenfs.com/en/globenewswire.com/e6eeab71f70356cc48046edfaa6b96f2"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/d3X3Kf.TCy_ExyT_flroVQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTEyNTtjZj13ZWJw/https://media.zenfs.com/en/globenewswire.com/e6eeab71f70356cc48046edfaa6b96f2","width":300,"height":89}},"lazy":false},{"type":"text","content":"Reference is made to the stock exchange announcement by Hofseth BioCare ASA ("HBC" or the "Company") on 27 October 2025 regarding (i) the completion of a private placement (the "Private Placement") of new shares in the Company the "Offer Shares"), the completion of which by delivery of Offer Shares in tranche 2 (the "T2 Offer Shares") is subject to, among other things, an extraordinary general meeting (the "EGM") resolving to issue the T2 Offer Shares in the Private Placement and (ii) a potential subsequent repair offering which is subject to the EGM authorising the Company's board of directors (the "Board") to issue new shares.","length":710,"tagName":"p"},{"type":"text","content":"The Board therefore calls for an EGM to be held at the offices of the Company at Keiser Wilhelms gate 24, Ålesund on 20 November 2025 at 11:00 hours CEST.","length":154,"tagName":"p"},{"type":"text","content":"The Company has already received voting undertakings from shareholders representing the necessary majority requirement to approve the Transaction and related resolutions at the EGM.","length":181,"tagName":"p"},{"type":"text","content":"For further information, please contact: Jon Olav Ødegård, CEO of Hofseth BioCare ASA Phone: +47 93632966 E-mail: [email protected]","length":143,"tagName":"p"},{"type":"text","content":"About Hofseth BioCare ASA: HBC is a Norwegian consumer and pet health company founded on the core values of sustainability, optimal utilization of natural resources and full traceability. It upcycles the side streams of the salmon industry by taking fresh filleted salmon and converting it from a waste product into ingredients to improve human and pet health.","length":361,"tagName":"p"},{"type":"text","content":"These ingredients...